481 related articles for article (PubMed ID: 2471275)
1. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
3. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
4. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of the myeloid growth factors.
Glaspy JA; Golde DW
Semin Hematol; 1989 Apr; 26(2 Suppl 2):14-7. PubMed ID: 2471274
[TBL] [Abstract][Full Text] [Related]
7. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
Steward WP; Scarffe JH; Bonnem E; Crowther D
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-assisted chemotherapy--the Manchester experience.
Crowther D; Scarffe JH; Howell A; Thatcher N; Bronchud M; Steward WP; Testa N; Dexter M
Ciba Found Symp; 1990; 148():201-10; discussion 211-4. PubMed ID: 1690624
[TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
Haematol Blood Transfus; 1990; 33():717-23. PubMed ID: 2182461
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factors: biology and clinical application.
Gabrilove JL; Jakubowski A
J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R
Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
Steward WP; Scarffe JH; Austin R; Bonnem E; Thatcher N; Morgenstern G; Crowther D
Br J Cancer; 1989 Jan; 59(1):142-5. PubMed ID: 2667607
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor.
Vadhan-Raj S; Velasquez WS; Butler JJ; LeMaistre A; Lepe-Zuniga J; Keating MJ; Koller CA; Gutterman JU
Am J Hematol; 1990 Mar; 33(3):189-97. PubMed ID: 2405649
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S
Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957
[TBL] [Abstract][Full Text] [Related]
19. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]